Pfizer is paying top dollar for a…
Pfizer is paying top dollar for a GLP-1 candidate from [...]
The long-planned legislation…
The long-planned legislation contains “encouraging steps” but is overall “not [...]
After winning an approval decades…
After winning an approval decades in the making last year—and [...]
About a year and a half after…
About a year and a half after telegraphing plans to [...]
After pressure from the FTC, Teva…
After pressure from the FTC, Teva has asked the FDA [...]
Eli Lilly has unveiled the…
Eli Lilly has unveiled the location of the third of [...]
With a new edition of a…
With a new edition of a long-running awareness campaign, Genentech [...]
Bora and Corealis are joining…
Bora and Corealis are joining forces to create a new [...]
A proposed combination of Johnson…
A proposed combination of Johnson & Johnson’s multiple myeloma bispecific [...]
Despite holding positive phase 3…
Despite holding positive phase 3 data that position its BTK [...]